Molecular basis of mantle cell lymphoma

British Journal of Haematology

Volumn 124, Issue 2, 2004, Pages 130-140

  Bertoni, Francesco ^a,b   Zucca, Emanuele ^a   Cotter, Finbarr E ^b  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ATM; Chromosome 11q; Cyclin D1; Immunoglobulin

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR; GENOMIC DNA; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN DERIVATIVE; PROTEIN P14; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P53;

B LYMPHOCYTE; CELL CYCLE; CHROMOSOME 11Q; CHROMOSOME 6P; CHROMOSOME ABERRATION; GENE; GENE DELETION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENOME; HUMAN; KARYOTYPE; LYMPHOID CELL; MANTLE CELL LYMPHOMA; MOLECULAR BIOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; GENE DELETION; GENE REARRANGEMENT; HUMANS; KARYOTYPING; LYMPHOMA, MANTLE-CELL; TRANSLOCATION, GENETIC;

EID: 1642539982     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04761.x     Document Type: Review

References (125)

1. Adams, J.M., Harris, A.W., Strasser, A., Ogilvy, S. & Cory, S. (1999) Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene, 18, 5268-5277.
2. Adams, J., Palombella, V.J. & Elliott, P.J. (2000) Proteasome inhibition: a new strategy in cancer treatment. Investigational New Drugs, 18, 109-121.
3. Allen, J.E., Hough, R.E., Goepel, J.R., Bottomley, S., Wilson, G.A., Alcock, H.E., Baird, M., Lorigan, P.C., Vandenberghe, E.A., Hancock, B.W. & Hammond, D.W. (2002) Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. British Journal of Haematology, 116, 291-298.
4. Au, W.Y., Horsman, D.E., Viswanatha, D.S., Connors, J.M., Klasa, R.J. & Gascoyne, R.D. (2000) 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica, 85, 1225-1227.
5. Bea, S., Ribas, M., Hernandez, J.M., Bosch, F., Pinyol, M., Hernandez, L, Garcia, J.L., Flores, T., Gonzalez, M., Lopez-Guillermo, A., Piris, M.A., Cardesa, A., Montserrat, E., Miro, R. & Campo, E. (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood, 93, 4365-4374.
6. Bea, S., Tort, F., Pinyol, M., Puig, X., Hernandez, L., Hernandez, S., Fernandez, P.L., van Lohuizen, M., Colomer, D. & Campo, E. (2001) BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Research, 61, 2409-2412.
7. Beishuizen, A., de Bruijn, M.A., Pongers-Willemse, M.J., Verhoeven, M.A., van Waring, E.R., Hahlen, K., Breit, T.M., de Bruin-Versteeg, S., Hooijkaas, H. & van Dongen, J.J. (1997) Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia, 11, 2200-2207.
8. Belaud-Rotureau, M.A., Parrens, M., Dubus, P., Garroste, J.C., de Mascarel, A. & Merlio, J.P. (2002) A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Modern Pathology, 15, 517-525.
9. Bentz, M., Plesch, A., Bullinger, L., Stilgenbauer, S., Ott, G., Muller-Hermelink, H.K., Baudis, M., Barth, T.F., Moller, P., Lichter, P. & Dohner, H. (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes, Chromosomes and Cancer, 27, 285-294.
10. Bertoni, F., Conconi, C, Cogliatti, S.B., Hsu Schmitz, S.-F., Ghielmini, M., Cerny, T., Fey, M., Pichert, G., Bertolini, F., Ponzoni, M., Baldini, L., Jones, C, Auer, R., Zucca, E., Cavalli, F. & Cotter, F.E. (2004) Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classical mantle cell lymphoma: a study from the Swiss Group for Clinical Cancer Research (SAKK). British Journal of Haematology, 124, 289-298.
11. Bertoni, F., Roggero, E., Luscieti, P., Pedrinis, E., Cavalli, F. & Zucca, E. (1999a) Clonality assessment in blood of patients with mantle cell lymphoma. Leukemia and Lymphoma, 32, 375-379.
12. Bertoni, F., Zucca, E., Genini, D., Cazzaniga, G., Roggero, E., Ghielmini, M., Cavalli, F. & Biondi, A. (1999b) Immunoglobulin light chain kappa deletion rearrangement as a marker of clonality in mantle cell lymphoma. Leukemia and Lymphoma, 36, 147-150.
13. Bigoni, R., Cuneo, A., Milani, R., Roberti, M.G., Bardi, A., Rigolin, G.M., Cavazzini, F., Agostini, P. & Castoldi, G. (2001) Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. Leukemia and Lymphoma, 40, 581-590.
14. Blagosklonny, M.V. & Pardee, A.B. (2002) The restriction point of the cell cycle. In: Cell Cycle Checkpoints (ed. by M.V. Blagosklonny). Landes Bioscience/Eurekah.com, Georgetown, TX, USA.
15. de Boer, C.J., Loyson, S., Kluin, P.M., Kluin-Nelemans, H.C., Schuuring, E. & van Krieken, J.H. (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Research, 53, 4148-4152.
16. Boultwood, J. (2001) Ataxia telangiectasia gene mutations in leukaemia and lymphoma. Journal of Clinical Pathology, 54, 512-516.
17. van der Burg, M., Tumkaya, T., Boerma, M., de Bruin-Versteeg, S., Langerak, A.W. & van Dongen, J.J. (2001) Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood, 97, 1001-1008.
18. Cabanillas, F. (2002) Management of Mantle Cell Lymphoma. ASCO Educational Book (Spring), pp. 416-419. American Society of Clinical Oncology, Alexandria.
19. Camacho, E., Hernandez, L., Hernandez, S., Tort, F., Bellosillo, B., Bea, S., Bosch, F., Montserrat, E., Cardesa, A., Fernandez, P.L. & Campo, E. (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol- 3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood, 99, 238-244.
20. Camacho, F.I., Algara, P., Rodriguez, A., Ruiz-Ballesteros, E., Mollejo, M., Martinez, N., Martinez-Climent, J.A., Gonzalez, M., Mateo, M., Caleo, A., Sanchez-Beato, M., Menarguez, J., Garcia-Conde, J., Sole, F., Campo, E. & Piris, M.A. (2003) Molecular heterogeneity in MCL, denned by the use of specific VH genes and the frequency of somatic mutations. Blood, 101, 4042-4046.
21. Campo, E., Raffeld, M. & Jaffe, E.S. (1999) Mantle-cell lymphoma. Seminars in Haematology, 36, 115-127.
22. Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., Lanza, C., Nomdedeu, J., Botto, B., Freilone, R., Buonaiuto, D., Zagonel, V., Gallo, E., Palestro, G., Saglio, G., Dalla-Favera, R., Carbone, A. & Gaidano, G. (2000) Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood, 95, 651-659.
23. Chaganti, S.R., Chen, W., Parsa, N., Offit, K., Louie, D.C., Dalla-Favera, R. & Chaganti, R.S. (1998) Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes, Chromosomes and Cancer, 23, 323-327.
24. Chiarle, R., Budel, L.M., Skolnik, J., Frizzera, G., Chilosi, M., Corato, A., Pizzolo, G., Magidson, J., Montagnoli, A., Pagano, M., Maes, B., De Wolf-Peeters, C. & Inghtrami, G. (2000) Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood, 95, 619-626.
25. Chiarle, R., Fan, Y., Piva, R., Boggino, H., Skolnik, I., Novero, D., Palestro, G., De Wolf-Peeters, C, Chilosi, M., Pagano, M. & Inghirami, G. (2002) S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. American Journal of Pathology, 160, 1457-1466.
26. Chibbar, R., Leung, K., McCormick, S., Ritzkalla, K., Strickler, J., Staggs, R., Poppema, S., Brunning, R.D. & McGlennen, R.C. (1998) bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis. Modern Pathology, 11, 1089-1097.
27. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 1764-1775.
28. Delves, P.J. & Roitt, I.M. (2000) The immune system. First of two parts. New England Journal of Medicine, 343, 37-49.
29. Dohner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. & Lichter, P. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516-2522.
30. Dreyling, M.H., Bullinger, L., Ott, G., Stilgenbauer, S., Muller-Hermelink, H.K., Bentz, M., Hiddemann, W. & Dohner, H. (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Research, 57, 4608-4614.
31. Dreyling, M.H., Scheubner, M., Maier, M., Hübler, K., German Ott, G. & Hiddemann, W. (2000) Allelotyping of mantle cell lymphoma identifies a new tumor suppressor region on 17p13.3. Blood, 96, 172b.
32. Dreyling, M., Meyer, T. & Hiddemann, W. (2001) Mantle cell lymphoma. In: Annual of Lymphoid Malignancies (ed. by F. Cavalli, J.O. Armitage & D.L. Longo), Vol. 1, pp. 61-68. Martin Dunitz, London.
33. Fan, H., Gulley, M.L., Gascoyne, R.D., Horsman, D.E., Adomat, S.A. & Cho, G.G. (1998) Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas. Diagnostic Molecular Pathology, 7, 209-214.
34. Fang, N.Y., Greiner, T.C., Weisenburger, D.D., Chan, W.C., Vose, J.M., Smith, L.M., Armitage, J.O., Mayer, R.A., Pike, B.L., Collins, F.S. & Hacia, J.G. (2003) Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 100, 5372-5377.
35. Ghielmini, M., Schmilz, S.F., Burki, K., Pichert, G., Betticher, D.C., Stupp, R., Wernli, M., Lohri, A., Schmitter, D., Bertoni, F. & Cerny, T. (2000) The effect of rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Annals of Oncology, 11, 123-126.
36. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R. & Weisenburger, D.D. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87, 4302-4310.
37. Gronbaek, K., Nedergaard, T., Andersen, M.K., thor Strafen, P., Guldberg, P., Moller, P., Zeuthen, J., Ebbe Hansen, N., Hou-Jensen, K. & Ralfkiaer, E. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia, 12, 1266-1271.
38. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
39. Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M.A., Piris, M.A., Montserrat, E., Cardesa, A., Jaffe, E.S., Campo, E. & Raffold, M. (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood, 87, 3351-3359.
40. Hernandez, L., Hernandez, S., Bea, S., Pinyol, M., Ferrer, A., Bosch, F., Nadal, A., Fernandez, P.L., Palacin, A., Montserrat, E. & Campo, E. (1999) c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia, 13, 2087-2093.
41. Hieter, P.A., Korsmeyer, S.J., Waldmann, T.A. & Leder, P. (1981) Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature, 290, 368-372.
42. Hoeve, M.A., Krol, A.D., Philippo, K., Derksen, P.W., Veenendaal, R.A., Schuuring, E., Kluin, P.M. & van Krieken, J.H. (2000) Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. Molecular Pathology, 53, 194-200.
43. Hofmann, W.K., de Vos, S., Tsukasaki, K., Wachsman, W., Pinkus, G.S., Said, J.W. & Koeffler, H.P. (2001) Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood, 98, 787-794.
44. Hummel, M., Tamaru, J., Kalvelage, B. & Stein, H. (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood, 84, 403-407.
45. Izban, K.F., Alkan, S., Singleton, T.P. & Hsi, E.D. (2000) Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma. Archives of Pathology and Laboratory Medicine, 124, 1457-1462.
46. Jacobs, H. & Bross, L. (2001) Towards an understanding of somatic hypermutation. Current Opinion in Immunology, 13, 208-218.
47. Katz, R.L., Caraway, N.P., Gu, J., Jiang, F., Pasco-Miller, L.A., Glassman, A.B., Luthra, R., Hayes, K.J., Romaguera, J.E., Cabanillas, F.F. & Medeiros, L.J. (2000) Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. American Journal of Clinical Pathology, 114, 248-257.
48. Kelsoe, G. (1999) V(D)J hypermutation and receptor revision: coloring outside the lines. Current Opinion in Immunology, 11, 70-75.
49. van Kemenade, F.J., Raaphorst, P.M., Blokzijl, T., Fieret, E., Hamer, K.M., Satijn, O.P., Otte, A.P. & Meijer, C.J. (2001) Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood, 97, 3896-3901.
50. Khanna, K.K. (2000) Cancer risk and the ATM gene: a continuing debate. Journal of the National Cancer Institute, 92, 795-802.
51. Knuutila, S., Bjorkqvist, A.M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M.L., Tapper, J., Pere, H., El-Rifai, W., Hemmer, S., Wasenius, V.M., Vidgren, V. & Zhu, Y. (1998) DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. American Journal of Pathology, 152, 1107-1123.
52. Knuutila, S., Aalto, Y., Autio, K., Bjorkqvist, A.M., El-Rifai, W., Hemmer, S., Huhta, T., Kettunen, E., Kiuru-Kuhlefelt, S., Larramendy, M.L., Lushnikova, T., Monni, O., Pere, H., Tapper, J., Tarkkanen, M., Varis, A., Wasenius, V.M., Wolf, M. & Zhu, Y. (1999) DNA copy number losses in human neoplasms. American Journal of Pathology, 155, 683-694.
53. Knuutila, S., Autio, K. & Aalto, Y. (2000) Online access to CGH data of DNA sequence copy number changes. American Journal of Pathology, 157, 689.
54. Kong, Q. & Maizels, N. (2001) DNA breaks in hypermutating immunoglobulin genes: evidence for a break- and-repair pathway of somatic hypermutation. Genetics, 158, 369-378.
55. Kouroukis, C.T., Belch, A., Crump, M., Eisenhauer, E., Gascoyne, R.D., Meyer, R., Lohmann, R., Lopez, P., Powers, J., Turner, R. & Connors, J.M. (2003) Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 21, 1740-1745.
56. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 1410-1416.
57. Küppers, R., Du, M.Q., Diss, T.C., Isaacson, P.G. & Pan, L.X. (1997) Ongoing somatic mutation in mantle cell lymphomas questioned. British Journal of Haematology, 97, 932-934.
58. Küppers, R., Klein, U., Hansmann, M.L. & Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. New England Journal of Medicine, 341, 1520-1529.
59. Kurokawa, T., Kinoshita, T., Murate, T., Nagasaka, T., Kagami, Y., Ogura, M., Nakamura, S., Seto, M., Hotta, T. & Saito, H. (1997) Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma. British Journal of Haematology, 98, 408-412.
60. Kwak, L.W. (2000) Therapeutic vaccines against hematological malignancies. In: Educational Book - Spring 2000 (ed. by M.C. Perry), pp. 349-352. American Society of Clinical Oncology, Alexandria, VA, USA.
61. Lai, R. & Medeiros, L.J. (2000) Pathologic diagnosis of mantle cell lymphoma. Clinical Lymphoma, 1, 197-206.
62. Laszlo, T., Nagy, M., Kelenyi, G. & Matolcsy, A. (2000) Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation. Leukemia Research, 24, 27-31.
63. Lavin, M.F., Concannon, P. & Gatti, R.A. (1999) Eighth international workshop on ataxia-telangiectasia (ATW8). Cancer Research, 59, 3845-3849.
64. Leroux, D., Le Marc'Hadour, F., Gressin, R., Jacob, M.C., Keddari, E., Monteil, M., Caillot, P., Jalbert, P. & Sotto, J.J. (1991) Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? British Journal of Haematology, 77, 346-353.
65. Li, J.Y., Gaillard, F., Moreau, A., Harousseau, J.L., Laboisse, C., Milpied, N., Bataille, R. & Avet-Loiseau, H. (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. American Journal of Pathology, 154, 1449-1452.
66. Liao, M.J. & Van Dyke, T. (1999) Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes & Development, 13, 1246-1250.
67. Lin, T.S., Howard, O.M., Neuberg, D.S., Kim, H.H. & Shipp, M.A. (2002) Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma. Leukemia & Lymphoma, 43, 793-797.
68. van Lohuizen, M. (1999) The trithorax-group and polycomb-group chromatin modifiers: implications for disease. Current Opinion in Genetics and Development, 9, 355-361.
69. Lovec, H., Grzeschiczek, A., Kowalski, M.B. & Moroy, T. (1994) Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO Journal, 13, 3487-3495.
70. Mabuchi, H., Fujii, H., Calin, G., Alder, H., Negrini, M., Rassenti, L., Kipps, T.J., Bullrich, F. & Croce, C.M. (2001) Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Research, 61, 2870-2877.
71. Magni, M., Di Nicola, M., Devizzi, L., Matteucci, P., Lombardi, F., Gandola, L., Ravagnani, F., Giardini, R., Dastoli, G., Tarella, C., Pileri, A., Bonadonna, G. & Gianni, A.M. (2000) Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. Blood, 96, 864-869.
72. Martinez-Climent, J.A., Vizcarra, E., Sanchez, D., Blesa, D., Marugan, I., Benet, I., Sole, F., Rubio-Moscardo, F., Terol, M.J., Climent, J., Sarsotti, E., Tormo, M., Andreu, E., Salido, M., Ruiz, M.A., Prosper, F., Siebert, R., Dyer, M.J. & Garcia-Conde, J. (2001) Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood, 98, 3479-3482.
73. Migliazza, A., Bosch, F., Komatsu, H., Cayanis, E., Martinotti, S., Toniato, E., Guccione, E., Qu, X., Chien, M., Murty, V.V., Gaidano, G., Inghirami, G., Zhang, P., Fischer, S., Kalachikov, S.M., Russo, J., Edelman, I., Efstratiadis, A. & Dalla-Favera, R. (2001) Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leuke-mia. Blood, 97, 2098-2104.
74. Moller, M.B., Nielsen, O. & Pedersen, N.T. (1999) Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities. Modern Pathology, 12, 1010-1016.
75. Monni, O., Oinonen, R., Elonen, E., Franssila, K., Teerenhovi, L., Joensuu, H. & Knuutila, S. (1998) Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes, Chromosomes and Cancer, 21, 298-307.
76. Monni, O., Zhu, Y., Franssila, K., Oinonen, R., Hoglund, P., Flonen, E., Joensuu, H. & Knuutila, S. (1999) Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma. British Journal of Haematology, 104, 665-671.
77. Onciu, M., Schlette, E., Medeiros, L.J., Abruzzo, L.V., Keating, M. & Lai, R. (2001) Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. American Journal of Clinical Pathology, 116, 886-892.
78. Orchard, J., Garand, R., Davis, Z., Babbage, G., Sahota, S., Matutes, E., Catovsky, D., Thomas, P.W., Avet-Loiseau, H. & Oscier, D. (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood, 101, 4975-4981.
79. Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, I.A. & Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 1177-1184.
80. Ott, G., Kalla, J., Ott, M.M., Schryen, B., Katzenberger, T., Muller, J.G. & Muller-Hermelink, H.K. (1997a) Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood, 89, 1421-1429.
81. Ott, M.M., Bartkova, J., Bartek, J., Durr, A., Fischer, L., Ott, G., Muller-Hermelink, H.K. & Kreipe, H. (1997b) Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood, 90, 3154-3159.
82. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Küppers, R. & Dalla-Favera, R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature, 412, 341-346.
83. Peng, H.Z., Du, M.Q., Koulis, A., Aiello, A., Dogan, A., Pan, L.X. & Isaacson, P.G. (1999) Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood, 93, 2167-2172.
84. Petiniot, L.K., Weaver, Z., Barlow, C., Shen, R., Eckhaus, M., Steinberg, S.M., Ried, T., Wynshaw-Boris, A. & Hodes, R.J. (2000) Recombinase- activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 6664-6669.
85. Pettitt, A.R., Sherrington, P.D., Stewart, G., Cawley, J.C., Taylor, A.M. & Stankovic, T. (2001) p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood, 98, 814-822.
86. Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lo, P. & Ford, R.J. (2003) Inhibition of constitutive NF-kappaB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Journal of Immunology, 171, 88-95.
87. Pileri, S.A., Ascani, S., Sabattini, E., Fraternali-Orcioni, G., Poggi, S., Piccioli, M., Piccaluga, P.P., Gamberi, B., Zinzani, P.L., Leoncini, L. & Falini, B. (2000) The pathologist's view point. Part II - aggressive lymphomas. Haematologica, 85, 1308-1321.
88. Pinyol, M., Cobo, F., Bea, S., Jares, P., Nayach, I., Fernandez, P.L., Montserrat, E., Cardesa, A. & Campo, E. (1998) p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood, 91, 2977-2984.
89. Pinyol, M., Hernandez, L., Martinez, A., Cobo, F., Hernandez, S., Bea, S., Lopez-Guillermo, A., Nayach, I., Palacin, A., Nadal, A., Fernandez, P.L., Montserrat, E., Cardesa, A. & Campo, E. (2000) INK4a/ ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. American Journal of Pathology, 156, 1987-1996.
90. Pittaluga, S., Tierens, A., Pinyol, M., Campo, E., Delabie, J. & De Wolf-Peeters, C. (1998) Elastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. British Journal of Haematology, 102, 1301-1306.
91. Pittaluga, S., Tierens, A., Dodoo, Y.L., Delabie, J. & De Wolf-Peeters, C. (1999) How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. American Journal of Clinical Pathology, 111, 179-184.
92. Press, O.W. (2002) Treatment of Mantle-cell Lymphoma: Stem-cell Transplantation, Radioimmunotherapy, and Management of Mantle-cell Lymphoma Subsets. ASCO Educational Book (Spring), pp. 407-415. American Society of Clinical Oncology, Alexandria.
93. Raaphorst, F.M., van Kemenade, F.J., Fieret, E., Hamer, K.M., Satijn, O.P., Otte, A.P. & Meijer, C.J. (2000) Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. Journal of Immunology, 164, 1-4.
94. Rimokh, R., Berger, F., Delsol, G., Digonnet, I., Rouault, J.P., Tigaud, J.D., Gadoux, M., Coiffier, B., Bryon, P.A. & Magaud, J.P. (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood, 83, 1871-1875.
95. Rosenwald, A., Ott, G., Krumdiek, A.K., Dreyling, M.H., Katzenberger, T., Kalla, J., Roth, S., Ott, M.M. & Muller-Hermelink, H.K. (1999) A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas? Genes, Chromosomes & Cancer, 26, 210-214.
96. Rosenwald, A., Wright, G., Wiestner, A., Chan, W.C., Connors, J.M., Campo, E., Gascoyne, R.D., Grogan, T.M., Muller-Hermelink, H.K., Smeland, E.B., Chiorazzi, M., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Montserrat, E., Bosch, F., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Fisher, R.I., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L.M. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, 185-197.
97. Schaffner, C., Idler, I., Stilgenbauer, S., Dohner, H. & Lichter, P. (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proceedings of the National Academy of Sciences of the United States of America, 97, 2773-2778.
98. Shapiro, G.I. (2001) Small molecule inhibitors of cyclin-dependent kinases: preclinical and clinical development. In: Cell Cycle Check-points (ed. by M.V. Blagosklonny). Landes Bioscience/Eurekah.com, Georgetown, TX, USA.
99. Sherr, C.J. (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Research, 60, 3689-3695.
100. Spring, K., Cross, S., Li, C., Watters, D., Ben-Senior, L., Waring, P., Ahangari, F., Lu, S.L., Chen, P., Misko, I., Paterson, C., Kay, G., Smorodinsky, N.I., Shiloh, Y. & Lavin, M.F. (2001) Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636de19 common mutation exhibit a variant phenotype. Cancer Research, 61, 4561-4568.
101. Stamatopoulos, K., Kosmas, C., Belessi, C., Kyriazopoulos, P., Papadaki, T., Anagnostou, D. & Loukopoulos, D. (1999) Molecular analysis of bcl-1/IgH functional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation. British Journal of Haematology, 105, 190-197.
102. Stankovic, T., Stewart, G.S., Fegan, C., Biggs, P., Last, J., Byrd, P.J., Keenan, R.D., Moss, P.A. & Taylor, A.M. (2002) Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood, 99, 300-309.
103. Stevenson, F.K. (1999) Vaccine strategies in indolent lymphomas. In: Hematology - American Society of Hematology Education Program Book, pp. 312-318. American Society of Hematology, Washington.
104. Stilgenbauer, S., Winkler, D., Ott, G., Schaffher, C., Leupolt, E., Bentz, M., Moller, P., Muller-Hermelink, H.K., James, M.R., Lichter, P. & Dohner, H. (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood, 94, 3262-3264.
105. Storb, U., Shen, H.M., Michael, N. & Kim, N. (2001) Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 356, 13-19.
106. Struski, S., Doco-Fenzy, M. & Cornillet-Lefebvre, P. (2002) Compilation of published comparative genomic hybridization studies. Cancer Genetics and Cytogenetics, 135, 63-90.
107. Swerdlow, S.H., Berger, F., Isaacson, P.I., Muller-Hermelink, H.K., Nathwani, B.N., Piris, M.A. & Harris, N.L. (2001) Mantle cell lymphoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 168-170. IARC Press, Lyon.
108. Taylor, W.R. & Stark, G.R. (2001) Regulation of the G2/M transition by p53. Oncogene, 20, 1803-1815.
109. The Non-Hodgkin's Lymphoma Classification Project. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, 3909-3918.
110. Theriault, C., Galoin, S., Valmary, S., Selves, J., Lamant, L., Roda, D., Rigal-Huguet, F., Brousset, P., Delsol, G. & Al Saati, T. (2000) PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Modern Pathology, 13, 1269-1279.
111. Tirier, C., Zhang, Y., Plendl, H., Weber-Matthiesen, K., Langer, W., Heit, W. & Schlegelberger, B. (1996) Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia, 10, 346-350.
112. Vanasse, G.J., Concannon, P. & Willerford, D.M. (1999) Regulated genomic instability and neoplasia in the lymphoid lineage. Blood, 94, 3997-4010.
113. Visser, H.P., Gunster, M.J., Kluin-Nelemans, H.C., Manders, E.M., Raaphorst, F.M., Meijer, C.J., Willemze, R. & Otte, A.P. (2001) The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. British Journal of Haematology, 112, 950-958.
114. Walsh, S.H., Thorselius, M., Johnson, A., Soderberg, O., Jerkeman, M., Bjorck, E., Eriksson, I., Thunberg, U., Landgren, O., Ehinger, M., Lofvenberg, E., Wallman, K., Enblad, G., Sander, B., Porwit-MacDonald, A., Dictor, M., Olofsson, T., Sundstrom, C., Roos, G. & Rosenquist, R. (2003) Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood, 101, 4047-4054.
115. Weisenburger, D.D. & Armitage, J.O. (2000) Mantle cell lymphoma. In: Malignant Lymphoma (ed. by B.W. Hancock, P.J. Selby, K. MacLennan & J.O. Armitage), pp. 27-41. Arnold, London.
116. Welzel, N., Le, T., Marculescu, R., Mitterbauer, G., Chott, A., Pott, C., Kneba, M., Du, M.Q., Kusec, R., Drach, J., Raderer, M., Mannhalter, C., Lechner, K., Nadel, B. & Jaeger, U. (2001) Templated nucleotide addition and immunoglobulin JH-gene utilization in t(ll;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Research, 61, 1629-1636.
117. Williams, M.E., Swerdlow, S.H., Rosenberg, C.L. & Arnold, A. (1993) Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia, 1, 241-245.
118. Wlodarska, I., Sestigiani, C., Gasco, M., Willis, T., Bastard, C., Chris De Wolf-Peeters, C., Dyer, M. & Hagemeijer, A. (2000) Identification of a 3 cm commonly deleted region in mantle cell lymphoma with chromosome 1p deletion. Blood, 96, 177b.
119. Wolf, S., Mertens, D., Schaffner, C., Korz, C., Dohner, H., Stilgenbauer, S. & Lichter, P. (2001) B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Human Molecular Genetics, 10, 1275-1285.
120. Zhu, Y., Monni, O., El-Rifai, W., Siitonen, S.M., Vilpo, L., Vilpo, J. & Knuutila, S. (1999) Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia. Leukemia, 13, 708-712.
121. Zhu, Y., Monni, O., Franssila, K., Elonen, E., Vilpo, J., Joensuu, H. & Knuutila, S. (2000) Deletions at 11q23 in different lymphoma subtypes. Haematologica, 85, 908-912.
122. Zoldan, M.C., Inghirami, G., Masuda, Y., Vandekerckhove, F., Raphael, B., Amorosi, E., Hymes, K. & Frizzera, G. (1996) Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. British Journal of Haematology, 93, 475-486.
123. Zucca, E., Stein, H. & Coiffier, B. (1994) European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Annals of Oncology, 5, 507-511.
124. Zucca, E., Soldati, G., Schlegelberger, B., Booth, M.J., Weber-Matthiesen, K., Cavalli, F. & Cotter, F.E. (1995) Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. British Journal of Haematology, 89, 665-668.
125. Zucca, E., Bertoni, F., Roggero, E. & Cavalli, F. (1998) Management of rare forms of lymphoma. Current Opinion in Oncology, 10, 377-384.